GLP-1 therapies are showing up in ophthalmic practice whether clinicians are ready for them or not, and the evidence on their ocular effects is as mixed as the patients taking them
If you have questions about compounded alternatives, your physician can walk through the current regulatory landscape and help you weigh the tradeoffs at your consultation
Customer Service: 3.5/5 Decent customer service
To put these results in perspective, this level of weight loss approaches or matches what has traditionally been achievable only through bariatric surgical procedures like Roux-en-Y gastric bypass or sleeve gastrectomy, which typically produce 25-35% weight loss
Substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimers disease and dementia), cardiometabolic disorders, chronic kidney disease, COPD, pneumonia, liver failure, inflammatory bowel disease, liver cancer) all significantly declined
When appetite is low, these portions feel manageablenot overwhelming